Paul Tabereaux, MD
Clinical Cardiac Electrophysiology · Huntsville, ALNPI 1578776241
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,134 of the $9,131 with a category attached, or 78.1%. 19 manufacturers reported payments, led by Boston Scientific at 26.9% of the total. Reporting peaked in 2024 at $3,448 and has fallen 63.9% since, to $1,244 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AL, where the typical reported total is $17,214.
Across 287 payments — averaging $31.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Atricure, Inc.$2K
- Abbott$2K
- Biosense Webster, Inc.$1K
- Medtronic$385
- Pfizer$206
- plus $689 from 13 others
Across 57 payments — averaging $4796.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$107K
- Boston Scientific$106K
- Abbott$47K
- Atricure, Inc.$13K
What the payments were for
- Travel & lodging$1,98322%
- Food & beverage$7,13478%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 115 | $2,456 |
| Atricure, Inc. | 13 | $2,403 |
| Abbott | 59 | $1,980 |
| Biosense Webster, Inc. | 49 | $1,012 |
| Medtronic(2 entities) | 14 | $385 |
| Pfizer | 13 | $206 |
| AstraZeneca | 6 | $158 |
| Philips North America LLC | 1 | $124 |
| Boehringer Ingelheim | 1 | $113 |
| Novartis | 3 | $53 |
| Convatec Inc. | 2 | $45 |
| Novo Nordisk | 2 | $41 |
| Johnson & Johnson | 2 | $32 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $31 |
| Abiomed | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Elutia, Inc. | 1 | $17 |
| Amgen | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,719
- ATRICLIP LAA EXCLUSION SYSTEM$1,238
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$1,238
- AVEIR$494
- Carto 3$295
- SYNERGY ABLATION SYSTEM$225
- ASSURITY$165
- WATCHMAN Access System$152
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$145
- Accent Pacemaker$140
- ACCOLADE SR$125
- (9525) EP Undivided$124
- Rhythmia Mapping System$114
- JARDIANCE$113
- PulseSelect$109
- RESONATE$108
How this compares
$9,131 in reported general payments places this provider in the 15th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 434 | $427,980 |
| XareltoRivaroxaban | 92 | $81,652 |
| MultaqDronedarone Hcl | 46 | $60,092 |
| EntrestoSacubitril/Valsartan | 15 | $15,449 |
| JardianceEmpagliflozin | 14 | $12,602 |
| Flecainide Acetate | 182 | $9,389 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 22 | $5,909 |
| Dofetilide | 17 | $4,482 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 101 | $2,392 |
| Amiodarone Hcl | 147 | $2,354 |
| Metoprolol Succinate | 144 | $2,183 |
| Propafenone Hcl ErPropafenone Hcl | 14 | $2,121 |
| SotalolSotalol Hcl | 77 | $2,114 |
| Digoxin | 37 | $843 |
| Colchicine | 61 | $576 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $206 | $427,980434 claims |
| Johnson & JohnsonXarelto | $32 | $81,65292 claims |
| NovartisEntresto | $53 | $15,44915 claims |
| Boehringer IngelheimJardiance | $113 | $12,60214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
Other clinical cardiac electrophysiology in Huntsville
- Jeffery AllisonHuntsville$18K
- John JenningsHuntsville$15K
- Michael KaufmannHuntsville$14K
- Jay DinermanHuntsville$13K
- Hugh McElderryBirmingham$725K
- Anil RajendraBirmingham$495K
- Gustavo MoralesBirmingham$171K
- William MaddoxBirmingham$159K
- Francis BennBirmingham$95K
- Terence DunnBirmingham$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.